[Influenza infection: An update for clinicians]

M Blot; P Chavanet; L Piroth

doi:10.1016/j.revmed.2018.12.010

[Influenza infection: An update for clinicians]

Rev Med Interne. 2019 Mar;40(3):158-165. doi: 10.1016/j.revmed.2018.12.010. Epub 2019 Jan 11.

[Article in French]

Authors

M Blot¹, P Chavanet², L Piroth²

Affiliations

¹ Département de maladies infectieuses et tropicales, CHU François-Mitterrand, 21000 Dijon, France; Inserm UMR 1231, Lipides/Nutrition/Cancer, université Bourgogne-Franche-Comté, 21000 Dijon, France. Electronic address: [email protected].
² Département de maladies infectieuses et tropicales, CHU François-Mitterrand, 21000 Dijon, France.

PMID: 30638964
DOI: 10.1016/j.revmed.2018.12.010

Abstract

Lower respiratory infections remain the deadliest communicable disease in the world. Influenza infections are particularly involved, whether intrinsically, or more frequently, by promoting bacterial infections and superinfections. The flu is also responsible for the decompensation of many comorbidities and could lead to some myocardial infarction and stroke. The effect of antiviral therapies is limited but preventives measures, such as vaccination, remain a major public health issue. The flu is a major challenge at all levels and all times, from vaccine prevention, to the recognition of atypical forms, and the early management of bacterial complications.

Keywords: Bacterial infections; Epidemics; Grippe; Infections bactériennes; Influenza; Mortality; Mortalité; Pandemics; Pandémies; Épidémies.

Publication types

Review

MeSH terms

Antiviral Agents / therapeutic use
Bacterial Infections / epidemiology
Bacterial Infections / therapy
Humans
Influenza Vaccines / therapeutic use
Influenza, Human* / epidemiology
Influenza, Human* / prevention & control
Influenza, Human* / therapy
Pandemics
Physician's Role
Vaccination / statistics & numerical data

Substances

Antiviral Agents
Influenza Vaccines